RNAC Cartesian Therapeutics, Inc.
Healthcare$6.45-4.44%ClosedMarket Cap: $189.5M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$20.50
Target (Median)
$20.50
Target Range
$16.00 - $25.00
Upside from current price: 217.8%
Rating Distribution
1 Strong Buy7 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-12 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-01 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-10 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-09 | Needham | maintain | Buy | Buy |
| 2026-03-09 | Cantor Fitzgerald | upgrade | Overweight | Neutral |
| 2026-01-09 | Needham | maintain | Buy | Buy |
| 2025-11-19 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-14 | BTIG | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-3.69 | $458.9K | 4 |
| Sun Dec 31 | $-3.41 | $23.8M | 5 |
| Mon Dec 31 | $-2.71 | $90.2M | 1 |
| Tue Dec 31 | $-1.06 | $217.8M | 1 |